Trademark: 97706107
Word
VERSÉA
Status Date
Wednesday, June 26, 2024
Filing Date
Tuesday, December 6, 2022
Published for Opposition
Tuesday, May 28, 2024
9 Downloadable mobile applications for use in telemedicine functionalities namely, remotely identifying and assessing health risks and the provision of information about products in the field of healthcare
16 Product packaging in the nature of cardboard boxes, plastic and cardboard bags, sheets, and blister packs for packaging; perishables packaging, namely, packaging containers comprised of cardboard for food, beverages, and agricultural products; food packaging, namely, packaging containers comprised of cardboard for food and beverage products
5 Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pregnancy testing preparations; ovulation test kits; pH test strips, namely, test strips for use in measuring the pH level in human bodies for purposes of determining levels of alkalinity in the body; diagnostic kits comprised of medical diagnostic test strips for use in disease detection, namely, urinary tract infection; diagnostic kits comprised of medical diagnostic test strips for use in the field of vaginal health; medical diagnostic test strips for use in the field of respiratory and infectious diseases; botanical therapeutic agents for promotion of general wellness; stem cells for medical purposes; pharmaceutical preparations for wounds; vitamins and dietary supplements; natural dietary supplements; dietary and nutritional supplements; mixed biological preparations for the prevention and treatment of infectious diseases; biological tissue cultures for medical purposes; biological bone or skin tissue intended for subsequent implantation; eye care, ophthalmology, and optometry products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, along with reader devices, sold together as a unit; pre-packaged laceration kits comprised of bandages for skin wounds, gauze, and materials to close lacerations; first-aid kits, filled
1 Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs
44 Healthcare services; healthcare screenings and personalized medicine services
10 Medical supplies, namely, sanitary masks for medical wellness purposes, medical gowns, medical apparel, namely, women's garment for use in medical examination and treatment, protective gloves for medical use, medical gloves, gloves for medical purposes, furniture especially made for medical purposes, bracelets for medical purposes, medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate, medical syringes, containers especially adapted for the disposal of medical instruments, syringes and other contaminated medical waste, medical patient treatment chairs, medical ice packs, medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; diagnostic kits consisting primarily of probes, buffers, and reagents for use in disease and microbial testing; medical apparatus for testing blood samples and DNA and RNA samples
42 Medical and scientific research; pharmaceutical research; research, testing, design, and development of pharmaceuticals; research, testing, design, and development of medical devices; research, testing, design, and development of biologics; research, testing, design, and development of product packaging; research, testing, design, and development of perishables packaging; research, testing, design, and development of food packaging; software as a service (SAAS) services, namely, providing a software platform that utilizes machine learning to assess and screen pharmaceutical drug candidates
20 Product packaging in the nature of plastic shipping boxes; perishables packaging, namely, packaging containers of plastic for food, beverages, and agricultural products; food packaging, namely, packaging containers comprised of plastic for food and beverage products; plastic boxes for packaging products
The mark consists of the word VERSÉA in a stylized font with an irregular trapezoid shape above it and a circle to the left of the irregular trapezoid shape.
Color is not claimed as a feature of the mark.
Jan 5, 2023
Notice Of Design Search Code E-Mailed
Dec 9, 2022
New Application Entered
Jan 4, 2023
New Application Office Supplied Data Entered
Jun 13, 2023
Assigned To Examiner
Jun 15, 2023
Non-Final Action Written
Jun 15, 2023
Non-Final Action E-Mailed
Jun 15, 2023
Notification Of Non-Final Action E-Mailed
Aug 30, 2023
Automatic Update Of Assignment Of Ownership
Sep 12, 2023
Application Extension To Response Period - Received
Sep 12, 2023
Application Extension Granted/Receipt Provided
Dec 13, 2023
Teas Response To Office Action Received
Dec 13, 2023
Correspondence Received In Law Office
Dec 14, 2023
Teas/Email Correspondence Entered
Jan 24, 2024
Non-Final Action Written
Jan 24, 2024
Non-Final Action E-Mailed
Jan 24, 2024
Notification Of Non-Final Action E-Mailed
Apr 24, 2024
Teas Response To Office Action Received
Apr 24, 2024
Correspondence Received In Law Office
Apr 24, 2024
Teas/Email Correspondence Entered
Apr 25, 2024
Examiners Amendment -Written
Apr 25, 2024
Examiners Amendment E-Mailed
Apr 25, 2024
Notification Of Examiners Amendment E-Mailed
Apr 25, 2024
Examiner's Amendment Entered
Apr 25, 2024
Approved For Pub - Principal Register
May 8, 2024
Notification Of Notice Of Publication E-Mailed
May 28, 2024
Published For Opposition
May 28, 2024
Official Gazette Publication Confirmation E-Mailed
Jun 26, 2024
Extension Of Time To Oppose Received
Trademark Alertz updated from USPTO on 2030-01-24
